Wednesday, February 8, 2023
  • Login
CEO North America
  • Home
  • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
    • Environment
  • Opinion
  • News
  • Multimedia
No Result
View All Result
  • Home
  • Business
    • Entrepreneur
    • Industry
    • Innovation
    • Management & Leadership
  • CEO Interviews
  • CEO Life
    • Art & Culture
    • Food
    • Health
    • Travel
    • Environment
  • Opinion
  • News
  • Multimedia
No Result
View All Result
CEO North America
No Result
View All Result

Felicitex Therapeutics Proposes IPO

in News
Felicitex therapeutics proposes ipo
Share on FacebookShare on Twitter

Felicitex Therapeutics said in a filing that it is considering offering 2.5M units priced at $6.25 per unit. That price could change. The Natick, Massachusetts-based company hopes to list its shares on Nasdaq under the symbol FLCT.

This oncology drug development company specializes in, therapies that target dormant cancer cells. When cancer cells are dormant, they can become therapy-resistant, metastasize, and recur. Felixitex is developing treatments that target both dormant and proliferating cancers for the deadliest and most therapy-resistant liquid and solid tumors: hematopoietic, ovarian, pancreatic, colorectal, osteosarcoma, glioblastoma, and lung.

Each IPO unit would consist of one share plus two warrants to buy one share apiece at the IPO price. The warrant exercise price would be reset after 90 days of issuance to a price that is at least 50% of the IPO unit price. Underwriters would receive a 45-day option to buy up to 372K additional shares and/or up to 744K warrants to cover any over-allotments. IPO proceeds will help fund research & development subsidize general corporate purposes and provide working capital. Aegis Capital Corp. is the sole underwriter on the deal. 

Tags: CancerFelicitex TherapeuticsIPOPharmacuetical

Related Posts

Super bowl betting projected to reach $16 billion this year
News

Super Bowl betting projected to reach $16 billion this year

Ev batteries getting second life on california power grid
News

EV batteries getting second life on California power grid

Microsoft investigates outlook outage as users face issues
News

Microsoft investigates Outlook outage as users face issues

Public storage makes $11 billion hostile bid for life storage
News

Public Storage makes $11 billion hostile bid for Life Storage

Drug companies face covid cliff in 2023 as sales set to plummet
News

Drug companies face COVID cliff in 2023 as sales set to plummet

Dell to slash over 6,000 jobs amid ‘uncertain market future’
News

Dell to slash over 6,000 jobs amid ‘uncertain market future’

U. S. Reports blowout job growth; unemployment rate lowest since 1969
News

U.S. reports blowout job growth; unemployment rate lowest since 1969

Honda issues ‘do not drive’ warning for 8,200 u. S. Vehicles over air bag risks
News

Honda issues ‘Do Not Drive’ warning for 8,200 U.S. vehicles over air bag risks

Dollar jumps as u. S. Employers add more jobs than expected in january
News

Dollar jumps as U.S. employers add more jobs than expected in January

Mortgage rates fall to the 5% range for first time since september
News

Mortgage rates fall to the 5% range for first time since September

No Result
View All Result

Recent Posts

  • Super Bowl betting projected to reach $16 billion this year
  • EV batteries getting second life on California power grid
  • 4 Surprises All Leaders Face
  • What’s hot this year in supply chain technology
  • Microsoft investigates Outlook outage as users face issues

Recent Comments

    Archives

    Categories

    • Art & Culture
    • Business
    • CEO Interviews
    • CEO Life
    • Editor´s Choice
    • Entrepreneur
    • Environment
    • Food
    • Health
    • Highlights
    • Industry
    • Innovation
    • Issues
    • Management & Leadership
    • Multimedia
    • News
    • Opinion
    • PrimeZone
    • Printed Version
    • Travel
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    • CONTACT
    • GENERAL ENQUIRIES
    • ADVERTISING
    • MEDIA KIT
    • DIRECTORY
    • TERMS AND CONDITIONS

    Editorials – stuart.james@ceo-na.com

    Editor-In-Chief – caroline.sposto@ceo-na.com

    Editorials – editorials@ceo-na.com

    Advertising – media@ceo-na.com

    NEW YORK

    110 Wall St.,
    3rd Floor
    New York, NY.
    10005
    USA
    +1 212 432 5800

     

    MEXICO CITY

    Paseo de la Reforma 296,
    Floor 38
    Mexico City
    06600
    MEXICO

    • CONTACT
    • GENERAL ENQUIRIES
    • ADVERTISING
    • MEDIA KIT
    • DIRECTORY
    • TERMS AND CONDITIONS

    Editorials –
    stuart.james@ceo-na.com

    Editor-In-Chief –

    caroline.sposto@ceo-na.com

    Editorials – editorials@ceo-na.com

    Advertising –
    media@ceo-na.com

    NEW YORK

    110 Wall St.,
    3rd Floor
    New York, NY.
    10005
    USA
    +1 212 432 5800

    MEXICO CITY

    Paseo de la Reforma 296,
    Floor 38
    Mexico City
    06600
    MEXICO

    CEO North America © 2022 - Sitemap

    No Result
    View All Result
    • Home
    • Business
      • Entrepreneur
      • Industry
      • Innovation
      • Management & Leadership
    • CEO Interviews
    • CEO Life
      • Art & Culture
      • Food
      • Health
      • Travel
      • Environment
    • Opinion
    • News
    • Multimedia

    © 2023 JNews - Premium WordPress news & magazine theme by Jegtheme.

    Welcome Back!

    Login to your account below

    Forgotten Password?

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In